Send to Kindle
This is totally cool … and may even be useful in fighting the bacteria that don’t respond to our current antibiotics!
According to Xconomy San Francisco, Sequenta Pockets $13M To Diagnose, Monitor Immune Systems Going Awry
The idea at Sequenta is to gather a new kind of information for physicians about whether a patient’s immune system has gone out of whack.
While the 3 billion letters of DNA that make up a genome are consistent in almost every cell of the body, the immune system’s B cells and T cells are an exception.
In these cells, DNA gets shuffled around in a vast array of combinations, allowing T cells to recognize specific invaders, such as flu viruses, and bacteria, and allowing B cells to generate antibodies against them.
Scientists wishing to assess immune response can look at generalized markers of inflammation like C-reactive protein.
But until recently, they could never really look at the vast diversity of an individual’s immune system in a specific way that could say how it reacted to infection with a specific bug, or adapted in response to a certain vaccine or therapy.
What do you think of this news? Please let me know in the comments below.
The post Sequenta Pockets $13M To Diagnose, Monitor Immune Systems Going Awry appeared first on Hampton & Associates, Scientific & Executive Search Services.